135 related articles for article (PubMed ID: 20097124)
1. Mexiletine suppresses nodal persistent sodium currents in sensory axons of patients with neuropathic pain.
Isose S; Misawa S; Sakurai K; Kanai K; Shibuya K; Sekiguchi Y; Nasu S; Noto Y; Fujimaki Y; Yokote K; Kuwabara S
Clin Neurophysiol; 2010 May; 121(5):719-24. PubMed ID: 20097124
[TBL] [Abstract][Full Text] [Related]
2. The effects of mexiletine on excitability properties of human median motor axons.
Kuwabara S; Misawa S; Tamura N; Kanai K; Hiraga A; Ogawara K; Nakata M; Hattori T
Clin Neurophysiol; 2005 Feb; 116(2):284-9. PubMed ID: 15661106
[TBL] [Abstract][Full Text] [Related]
3. Increased nodal persistent Na+ currents in human neuropathy and motor neuron disease estimated by latent addition.
Tamura N; Kuwabara S; Misawa S; Kanai K; Nakata M; Sawai S; Hattori T
Clin Neurophysiol; 2006 Nov; 117(11):2451-8. PubMed ID: 16996798
[TBL] [Abstract][Full Text] [Related]
4. Latent addition in human motor and sensory axons: different site-dependent changes across the carpal tunnel related to persistent Na+ currents.
Kuwabara S; Misawa S; Tamura N; Nakata M; Kanai K; Sawai S; Ogawara K; Hattori T
Clin Neurophysiol; 2006 Apr; 117(4):810-4. PubMed ID: 16497550
[TBL] [Abstract][Full Text] [Related]
5. Neuropathic pain is associated with increased nodal persistent Na(+) currents in human diabetic neuropathy.
Misawa S; Sakurai K; Shibuya K; Isose S; Kanai K; Ogino J; Ishikawa K; Kuwabara S
J Peripher Nerv Syst; 2009 Dec; 14(4):279-84. PubMed ID: 20021569
[TBL] [Abstract][Full Text] [Related]
6. Changes in excitability properties associated with axonal regeneration in human neuropathy and mouse Wallerian degeneration.
Sawai S; Kanai K; Nakata M; Hiraga A; Misawa S; Isose S; Hattori T; Kuwabara S
Clin Neurophysiol; 2008 May; 119(5):1097-105. PubMed ID: 18342570
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic concentrations of local anaesthetics unveil the potential role of sodium channels in neuropathic pain.
Strichartz GR; Zhou Z; Sinnott C; Khodorova A
Novartis Found Symp; 2002; 241():189-201; discussion 202-5, 226-32. PubMed ID: 11771646
[TBL] [Abstract][Full Text] [Related]
8. Changes of the peripheral nerve excitability in vivo induced by the persistent Na+ current blocker ranolazine.
Nodera H; Rutkove SB
Neurosci Lett; 2012 Jun; 518(1):36-40. PubMed ID: 22575609
[TBL] [Abstract][Full Text] [Related]
9. Changes in Na(+) channel expression and nodal persistent Na(+) currents associated with peripheral nerve regeneration in mice.
Nakata M; Baba H; Kanai K; Hoshi T; Sawai S; Hattori T; Kuwabara S
Muscle Nerve; 2008 Jun; 37(6):721-30. PubMed ID: 18506710
[TBL] [Abstract][Full Text] [Related]
10. Pulsed magnetic field therapy in refractory neuropathic pain secondary to peripheral neuropathy: electrodiagnostic parameters--pilot study.
Weintraub MI; Cole SP
Neurorehabil Neural Repair; 2004 Mar; 18(1):42-6. PubMed ID: 15035963
[TBL] [Abstract][Full Text] [Related]
11. Median-radial sensory nerve comparative studies in the detection of median neuropathy at the wrist in diabetic patients.
Imada M; Misawa S; Sawai S; Tamura N; Kanai K; Sakurai K; Sakamoto S; Nomura F; Hattori T; Kuwabara S
Clin Neurophysiol; 2007 Jun; 118(6):1405-9. PubMed ID: 17452013
[TBL] [Abstract][Full Text] [Related]
12. Differences in excitability between median and superficial radial sensory axons.
Fujimaki Y; Kanai K; Misawa S; Shibuya K; Isose S; Nasu S; Sekiguchi Y; Ohmori S; Noto Y; Kugio Y; Shimizu T; Matsubara S; Lin CS; Kuwabara S
Clin Neurophysiol; 2012 Jul; 123(7):1440-5. PubMed ID: 22204921
[TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.
Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC
Brain; 2009 Oct; 132(Pt 10):2712-23. PubMed ID: 19745023
[TBL] [Abstract][Full Text] [Related]
14. Skin denervation, neuropathology, and neuropathic pain in a laser-induced focal neuropathy.
Chiang HY; Chen CT; Chien HF; Hsieh ST
Neurobiol Dis; 2005 Feb; 18(1):40-53. PubMed ID: 15649695
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic intervention in axonal excitability: in vivo assessment of nodal persistent sodium currents in human neuropathies.
Kuwabara S; Misawa S
Curr Mol Pharmacol; 2008 Jan; 1(1):61-7. PubMed ID: 20021424
[TBL] [Abstract][Full Text] [Related]
16. Mexiletine and lidocaine suppress the excitability of dorsal horn neurons.
Olschewski A; Schnoebel-Ehehalt R; Li Y; Tang B; Bräu ME; Wolff M
Anesth Analg; 2009 Jul; 109(1):258-64. PubMed ID: 19535719
[TBL] [Abstract][Full Text] [Related]
17. Nodal persistent Na+ currents in human diabetic nerves estimated by the technique of latent addition.
Misawa S; Kuwabara S; Kanai K; Tamura N; Nakata M; Ogawara K; Yagui K; Hattori T
Clin Neurophysiol; 2006 Apr; 117(4):815-20. PubMed ID: 16495151
[TBL] [Abstract][Full Text] [Related]
18. Axonal excitability properties in amyotrophic lateral sclerosis.
Vucic S; Kiernan MC
Clin Neurophysiol; 2006 Jul; 117(7):1458-66. PubMed ID: 16759905
[TBL] [Abstract][Full Text] [Related]
19. Mutation in the Na+ channel subunit SCN1B produces paradoxical changes in peripheral nerve excitability.
Kiernan MC; Krishnan AV; Lin CS; Burke D; Berkovic SF
Brain; 2005 Aug; 128(Pt 8):1841-6. PubMed ID: 15857929
[TBL] [Abstract][Full Text] [Related]
20. Differential contribution of sodium channel subtypes to action potential generation in unmyelinated human C-type nerve fibers.
Lang PM; Hilmer VB; Grafe P
Anesthesiology; 2007 Sep; 107(3):495-501. PubMed ID: 17721253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
